19 results about "Diagnostic test" patented technology

Method, system, apparatus, and computer-readable media for reporting an automated medical opinion, including receiving, via a user interface, patient medical history, diagnostic tests, and current symptoms for a user; identifying, as automated output from a trained model, a diagnostic assessment including one or more of a medical diagnosis, a recommended medical treatment, or an recommended diagnostic medical test based on the patient medical history, diagnostic tests, and current symptoms received via the user interface; sending a report to the user based on the diagnostic assessment; receiving, via a feedback loop, feedback for the diagnostic assessment reported to the user; and updating the trained model based on the feedback.

In one embodiment, there is provided a device for performing a plurality of respiratory diagnostic tests, comprising: a housing, a sensor assembly, and control circuitry configured to receive signals from the sensor assembly; wherein the device has a first configuration in which the device is configured to perform a first respiratory diagnostic test and a second configuration in which the device is configured to perform a second respiratory diagnostic test, wherein in the first configuration an airflow channel is defined through the device housing, the sensor assembly being configured to measure at least a first property of air in the airflow channel during the first respiratory diagnostic test, and wherein in the second configuration the airflow channel is modified relative to the first configuration, the sensor assembly being used to measure at least a second property of air in the airflow channel during the second respiratory diagnostic test. In another embodiment there is provided a stand-alone device is designed for performing an impulse oscillometry test.

Embodiments of the present application provide a LIN diagnostic test method, an electronic device and a storage medium. The method comprises: sending a diagnostic request message to a target LIN node by a domain controller; if the node address is the same as the target node address of the target LIN node and the data identifier is the same as the target data identifier of the target LIN node, determining whether the LIN controller of the target LIN node supports long frames; if the LIN controller supports long frames, sending a first frame of diagnostic response message after a first delay time; sending a continuous frame of diagnostic response message after a second delay time; and when the sending of the diagnostic response message is completed, if the data identifier in the diagnostic response message is the same as the target data identifier and the response value in the diagnostic response message matches the expected LIN diagnostic response value, determining that the diagnostic service of the domain controller is qualified. Through pre-configuring LIN diagnostic test parameters and pre-designing a LIN diagnostic test method, embodiments of the present application realize full-automatic domain controller LIN diagnostic testing, and effectively improve the test efficiency and reliability.

Provided herein are methods for determining a personalized risk assessment for a subject from one or more biometric data streams of the subject using a multimodal machine learning algorithm to establish personalized benchmark profile by: identifying for each of the normalized biometric data stream values for: minimum, maximum, delta, mean, median, and average minimum and average maximum boundaries; reducing noise from non-essential features by cross feature linear regression analysis to obtain a dimensionality reduction; and stratifying each of two or more normalized biometric data stream values into nodes with a high or maximum predictive value and minimum predictive value selected to calculate the personalized risk assessment; using nodes with high or maximum predictive value to identify biometric data values for the personalized risk assessment; and administering or conducting at least one of: post-disease recovery, post-procedure monitoring, diagnostic tests, or treatment to the subject based on the personalized risk assessment.

The present disclosure relates to a liquid handling device, methods of operating a liquid handling device, a method of performing a diagnostic test, a computer program and a system. In particular, the liquid handling device is capable of controllable bi-directional or multi-directional flow of reagents across one or more reaction zones allowing rapid, precise and controllable quenching of reactions and / or biological interactions.

Controls for the identification of various genotypes and / or for the identification or characterization of a disease or condition are described. These controls can be especially useful for diagnostic tests that use circulating cell-free DNA or microRNA. A control may consist of a mixture of nucleic acids. In some formulations, a control comprises liposomes, for example, where the nucleic acids of the control are associated with the liposomes. For example, controls are useful for determining whether a fetus has aneuploidy. Methods for using these controls are also described.

Methods and systems for the detection and diagnosis of diseases, including cancer. [Solution] A patient's sample is analyzed by absorption spectroscopy in the near-infrared and mid-infrared ranges to create a spectral signature, and the sample is obtained from the patient. This signature is processed by a computational engine using one or more machine learning techniques to determine whether the spectral signature indicates the presence of a disease, including one or more cancers. The embodiment operates outside the conventionally accepted wavelength range, facilitating faster, simpler, and more reliable testing.

The present invention relates to diagnostic test devices that provide enhanced communication to a user regarding either the proper functioning of the test device or an analog test result provided by the test device. The diagnostic test devices may include one or more sensors effective for indicating the application of a sufficient volume of a test fluid and / or may include one or more light sources positioned to illuminate the analog test result to improve its visibility and understanding.

1. Name of the designed product: end of the ridge of the cover of the testing equipment. 2. Use of the designed product: testing equipment for diagnosis testing as a whole, cover of the testing equipment as a part. 3. Design points of the designed product: the shape of the claimed part. 4. Picture or photograph best indicating the design points: perspective view.

The present invention relates to a method for performing a liquid phase immunoassay using a diagnostic test cartridge having a magnetic bead well, a reaction well, a washing well, and a measurement well. The liquid phase immunoassay method of the present invention includes a step of bringing a magnet close to a pipette tip to capture and transfer magnetic beads filled in the magnetic bead well to the reaction well, a step of providing a sample to the reaction well to perform an antigen-antibody reaction, a step of bringing the magnet close to the pipette tip to capture and transfer a reaction in the reaction well to the pipette tip and to the washing well to perform washing, and a step of bringing the magnet close to the pipette tip to transfer the reaction after washing in the washing well to the measurement well and to perform optical analysis. According to the present invention, the capture yield of magnetic beads can be improved.

According to the invention, a diagnostic testing device is provided that comprises a plurality of detection chambers that are arranged in a geometric pattern. Each detection chamber comprises a receptacle for a sample container (14) containing a sample to be tested for luminescence. The diagnostic testing device further comprises a plurality of sensors, each sensor being assigned to a respective one of the detection chambers, energy supply means, a wireless data interface, a controller and a data memory. The data memory comprises a data structure, for instance a data base, wherein for each detection chamber a plurality of entries are provided that each are assigned to one individual detection chamber. The plurality of entries assigned to an individual detection chamber comprises at least an entry that indicates the presence or absence of a testing chamber in the individual detection chamber and an entry that indicates a detection or non-detection of a diagnostic feature by the sensor of the individual testing chamber.

The present invention relates to a fish pathogenic virus, provisionally called Labeo cichlid herpesvirus (LCHV), which causes a disease in fish, cell cultures comprising said virus, DNA fragments of said virus and the corresponding proteins, vaccines based on said virus, DNA and / or proteins and antibodies reacting with said virus and diagnostic test kits for detecting said virus.

The application relates to a SENT sensor fault diagnosis test system and method based on an HIL platform, and aims to solve the technical problem that the fault diagnosis test result of a SENT sensor signal of an existing fault diagnosis test system based on an HIL platform is not accurate enough. The application provides a SENT sensor fault diagnosis test system based on an HIL platform, a software platform is constructed by setting a whole vehicle physical model, a ConfigurationDesk unit, a ControlDesk unit and PicoScope software, an HIL test cabinet is set, a hardware platform is built by a diagnosis test unit, and the SENT sensor fault diagnosis test system based on the HIL platform is established.

An electronic diagnostics device can detect and report environmental conditions from manufacture to use. The device can include a reaction chamber configured to receive a biological sample and contain a reaction with the biological sample. A component of the biological sample can be detected based on the reaction. The device can also include one or more environmental sensors, such as a temperature sensor and a humidity sensor, to detect the environmental conditions. A processor can read data from the environmental sensors and compare the measured conditions to specified ranges. If an environmental parameter falls outside the specified range, the processor can disable the device or communicate to a user that the device should not be used to perform a diagnostic test.

Detection reagents, multi-analyte test elements, test systems, and multi-analyte measuring methods are provided. In particular, multi-analyte test elements have (1) a first working electrode and first counter electrode pair covered with a first analyte-specific reagent that includes an enzyme, a coenzyme and a first mediator and have (2) a second working electrode covered with a second analyte-specific reagent that includes an enzyme, a coenzyme and a second mediator, where the second mediator is different than the first mediator. The single counter electrode can be used as the counter electrode for both the first and second analyte measurements at their respective working electrodes. Moreover, the mediator concentrations, measurement ranges, and applied potential differences are not the same for each analyte-specific measurement.

This invention is in the field of medicine. More particularly the invention is in the field of treating sepsis and related disorders, and disorder wherein certain cytokines are elevated. The invention further relates to treating diseases where cytokines need to be suppressed. Further described is a companion diagnostic test.

The present application relates to a kind of protein markers for diagnosing postmenopausal osteoporosis and its application, belong to biological medicine technical field.The present application is screened, and it is found that NADH dehydrogenase 1 beta subcomplex subunit 4, NADH dehydrogenase 1 beta subcomplex subunit 5, NADH dehydrogenase 1 beta subcomplex subunit 6, NADH dehydrogenase 1, NADH dehydrogenase 1 alpha subcomplex subunit 8, cytochrome c oxidase subunit 7C, cytochrome c oxidase subunit 5A and cytochrome c oxidase subunit 7A2 can be used alone or in combination in the diagnosis test of postmenopausal osteoporosis, to accurately evaluate the PMOP state of subject.Further, the combination of NDUB5 and NDUA8 two protein markers shows excellent diagnostic sensitivity and specificity, which is helpful for early diagnosis of PMOP, screening of high-risk population of fracture and precise prevention and treatment.

The present invention provides methods for obtaining human induced pluripotent stem cell (hiPSC)-derived neuronal cells, which can be used in the diagnosis of neurological disorders associated with the presence of neuronal antibodies. In particular, the present invention provides methods for obtaining hiPSC-derived neuronal cells, wherein the method comprises culturing neural progenitor cells in a neurotrophic medium for at least three weeks under optimized conditions. The present invention also covers the use of neuronal cells obtained by the methods of the present invention as diagnostic tests in neurological disorders associated with the presence of neuronal antibodies and kits comprising the same.

There is provided a method of providing clinical decision support information for disease identification and therapy determination comprising: receiving a test result obtained using one or more diagnostic test reagent products selected based on sample information, from a target terminal; obtaining, based on the received test result, clinical decision support information for disease identification and therapy determination applicable to the one or more diagnostic test reagent products from a product-tailored database; and providing the obtained clinical decision support information for disease identification and therapy determination to the target terminal or a terminal associated with the target terminal.